CA2000650A1 - Produit et procede pour le traitement et la prevention des thrombi intravasculaires et de l'atherosclerose - Google Patents

Produit et procede pour le traitement et la prevention des thrombi intravasculaires et de l'atherosclerose

Info

Publication number
CA2000650A1
CA2000650A1 CA 2000650 CA2000650A CA2000650A1 CA 2000650 A1 CA2000650 A1 CA 2000650A1 CA 2000650 CA2000650 CA 2000650 CA 2000650 A CA2000650 A CA 2000650A CA 2000650 A1 CA2000650 A1 CA 2000650A1
Authority
CA
Canada
Prior art keywords
heparin
treatment
atherosclerosis
prevention
vascular
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2000650
Other languages
English (en)
Inventor
Louis Jaques
Thomas Usher
Linda Hiebert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA 2000650 priority Critical patent/CA2000650A1/fr
Publication of CA2000650A1 publication Critical patent/CA2000650A1/fr
Abandoned legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA 2000650 1989-10-13 1989-10-13 Produit et procede pour le traitement et la prevention des thrombi intravasculaires et de l'atherosclerose Abandoned CA2000650A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2000650 CA2000650A1 (fr) 1989-10-13 1989-10-13 Produit et procede pour le traitement et la prevention des thrombi intravasculaires et de l'atherosclerose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2000650 CA2000650A1 (fr) 1989-10-13 1989-10-13 Produit et procede pour le traitement et la prevention des thrombi intravasculaires et de l'atherosclerose

Publications (1)

Publication Number Publication Date
CA2000650A1 true CA2000650A1 (fr) 1991-04-13

Family

ID=4143324

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2000650 Abandoned CA2000650A1 (fr) 1989-10-13 1989-10-13 Produit et procede pour le traitement et la prevention des thrombi intravasculaires et de l'atherosclerose

Country Status (1)

Country Link
CA (1) CA2000650A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922690A (en) * 1996-04-25 1999-07-13 Van Gorp; Cornelius L. Dermatan disulfate, an inhibitor of thrombin generation and activation
US6409987B1 (en) 1999-04-07 2002-06-25 Intimax Corporation Targeted agents useful for diagnostic and therapeutic applications
US6518244B2 (en) 2000-03-09 2003-02-11 Intimax Corporation Combinations of heparin cofactor II agonist and platelet IIb/IIIa antagonist, and uses thereof

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5922690A (en) * 1996-04-25 1999-07-13 Van Gorp; Cornelius L. Dermatan disulfate, an inhibitor of thrombin generation and activation
US6409987B1 (en) 1999-04-07 2002-06-25 Intimax Corporation Targeted agents useful for diagnostic and therapeutic applications
US6518244B2 (en) 2000-03-09 2003-02-11 Intimax Corporation Combinations of heparin cofactor II agonist and platelet IIb/IIIa antagonist, and uses thereof

Similar Documents

Publication Publication Date Title
EP0343241B1 (fr) Procede inhibant la thrombose arterielle due aux plaquettes
DE69212608T2 (de) Arzneimittel enthaltend oral absorbierbare Glycosaminoglycane
JP3388117B2 (ja) カイガンショウ抽出物に基づく血小板反応性調節剤の調製方法
RU2262933C2 (ru) Медицинские композиции, содержащие аспирин
KR950009094B1 (ko) 과유지질혈증 및 아테롬성 동맥경화증의 방지 및 치료용 피리독신 유도체를 함유한 제약학적 조성물
EA004047B1 (ru) Применение глицинбетаина в качестве антитромботического средства
JP2004534087A (ja) 炎症性腸疾患の治療のためのスロデキシドの使用
US5230996A (en) Use of ascorbate and tranexamic acid solution for organ and blood vessel treatment prior to transplantation
Bird et al. Disseminated intravascular coagulation, antiphospholipid antibodies, and ischaemic necrosis of extremities.
Crepaldi et al. Double-blind multicenter trial on a new medium molecular weight glycosaminoglycan current therapeutic effects and perspectives for clinical use
US4302577A (en) Process for preparing CSA or CSC
KR20140097132A (ko) 허혈성 손상을 치료하기 위한 시스테아민 및/또는 시스타민
JP2010013455A (ja) 体外血液回路における血餅形成を防止するためのオリゴ糖の使用
Dressman et al. Absorption of flurbiprofen in the fed and fasted states
CA2441948A1 (fr) Glycine-betaine et utilisation correspondante
JPH05504785A (ja) 新規なへパリン誘導体
WO2004037242A1 (fr) Compositions injectables indolores contenant un sel d'acides 2-arylpropioniques
CA2000650A1 (fr) Produit et procede pour le traitement et la prevention des thrombi intravasculaires et de l'atherosclerose
JP2000026300A (ja) 血管内皮細胞保護医薬組成物
EP0532706B1 (fr) REDUCTION D'OCCLUSIONS DE VAISSEAUX CARDIOVASCULAIRES A L'AIDE D'ASCORBATE ET D'INHIBITEURS DE LIAISON DE LA LIPOPROTEINE (a)
IE891356L (en) Method of preventing or reducing venous thrombosis using a¹thromboxane a2 receptor antagonist in conjunction with¹heparin and combination
TW577741B (en) Novel pharmaceutical combination for treating pain comprising paracetamol and buspirone
Smeets et al. Influence of low dose allopurinol on ischaemia—Reperfusion injury during abdominal aortic surgery
CA2195863C (fr) Remede contre l'endotoxinemie et des defaillances d'organes multiples induites par celle-ci
WO2000018418A3 (fr) Inhibition de la falciformation des erythrocytes par n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead